Customer Testimonials

At RegSmart, every assignment matters, whether large or small. Our expert team supports life science, pharma and medtech companies with tailored regulatory strategies designed to reduce risk, ensure compliance and accelerate market access.

From pharmacovigilance and scientific advice to clinical trial applications and combination products, we cover the full spectrum of regulatory challenges across the product lifecycle.

What truly sets us apart is our dedication to quality and long-term partnerships. Clients value our ability to simplify complex regulatory processes, offer pragmatic solutions that work in practice, and provide clarity in every stage of development.

Whether navigating device regulations, medicinal product requirements or both, our mission is always the same. To guide you with confidence and ensure your innovation reaches patients safely and efficiently.

Explore our customer testimonials and success stories below to see how life science companies describe their experience with RegSmart, and why they continue to rely on our regulatory expertise for their most critical projects.

Customer Testimonials

“RegSmart has been very helpful for us in understanding the regulatory requirements for our innovative solution”

“It is essential for us to work with partners who understand both the scientific challenges and the business aspects of vaccine development.”

“RegSmart has been a valuable partner for us in clarifying the regulatory pathway for our development programs.”

“Beyond their expertise, the team’s warm and approachable personalities made the collaboration a true pleasure.”

“Their guidance enables us to stay agile in innovation while confidently advancing our clinical and regulatory development.”

NanoEcho

Improving rectal cancer diagnosis

NanoEcho is developing a diagnostic method to improve rectal cancer treatment. RegSmart provided regulatory expertise for their combination product, ensuring compliance across both pharma and medtech frameworks.

Abera Bioscience

The next generation mucosal vaccines

Abera Bioscience develops innovative mucosal vaccines to prevent infectious diseases. With RegSmart’s regulatory guidance, the company has advanced its projects efficiently and confidently - supported by clear communication and trusted expertise in life science.

Gesynta Pharma

Anti-inflammatory, pain-relieving pharmaceuticals

Gesynta Pharma focuses on developing safe, non-hormonal treatments for endometriosis and inflammatory diseases. RegSmart helped define their regulatory strategy and supported clinical development with scientific understanding and regulatory precision.

OnDosis

Revolutionizing how patients take medicines

OnDosis combines digital technology and pharmaceuticals to create personalized treatments. RegSmart supported the company in navigating complex combination product regulations throughout their product development journey.

Triomed AB

Rethinking peritoneal dialysis

Triomed AB is pioneering Steady Concentration Peritoneal Dialysis (SCPD) technology. RegSmart’s dual expertise in pharma and medtech has been key in guiding their Carry Life UF system through complex regulatory pathways and clinical evaluations.